{"id": "1335776477397151744", "creation": 1607308904.0, "user_id": "44900754", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 62, "reply_count": 1, "like_count": 1852, "quote_count": 0}}, "text": "Good news! \nThe day after #Pfizer applied for approval, #SerumInstitute of India, the first Indian company has applied  for emergency permission for conducting trials for the #COVID19 #Vaccine.", "first_save": 1634559108.199414, "hashtags": ["#PFIZER", "#SERUMINSTITUTE", "#COVID19", "#VACCINE"]}